BiotechTube
Home/Aptamer Group/Andrew Rapson
AR

Andrew Rapson

Chief Financial Officer and Company Secretary

Aptamer Group

Therapeutic Areas

OncologyNeurologyMetabolism

Aptamer Group Pipeline

DrugIndicationPhase
Alzheimer's Disease Diagnostic ReagentsAlzheimer's Disease Biomarker DetectionDevelopment
Targeted siRNA Delivery (AstraZeneca Collab)siRNA DeliveryDiscovery/Development
Consumer Cosmetic Innovation (Unilever)Cosmetic ApplicationsDevelopment

Leadership Team at Aptamer Group

DA
Dr. Adam Hargreaves
Non-Executive Chair
DA
Dr. Arron Tolley
Chief Executive Officer
DD
Dr. David Bunka
Chief Scientific Officer
TS
Tim Sykes
Non-Executive Director
PP
Prof. Paul Townsend
Scientific Advisory Board
DS
Dr. Shozo Fujita
Scientific Advisory Board
DP
Dr. Paloma Giangrande
Scientific Advisory Board
DL
Dr. Louis Allott
Scientific Advisory Board
View full Aptamer Group profile